AQST

NASDAQStock

Aquestive Therapeutics, Inc.

$4.00-0.04 (-0.87%)

52-Week Range

$2.22

$7.49

Key Stats

Market Cap

396.7M

P/E Ratio

—

Dividend Yield

—

Beta

1.59

Volume

1.4M

Avg Volume

2.4M

Performance

+7.47%

-31.81%

-21.60%

YTD

-37.52%

+41.90%

+455.86%

-27.52%

Price Chart

ETF Exposure

AQST is held by 61 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	28	$120	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	13	$53	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	162	$647	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	5,787	$23K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	27	$111	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	7,224	$21K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	3,294,909	$9.7M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	17,330	$69K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,494	$6K	$1.29B	0.17%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	158,509	$53K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	158,509	$16K	$3.91B	0.07%

PreviousPage 2 of 2

About AQST ETF Exposure

Aquestive Therapeutics, Inc. (AQST) is held by 61 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 396.7M, AQST is a widely held institutional stock. The stock currently trades at $4.00. Investors can gain exposure to AQST through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AQST, sorted by portfolio weight.